These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 31609532

  • 21. Homocysteine levels are independently associated with damage accrual in systemic lupus erythematosus patients from a Latin-American cohort.
    Zeña-Huancas PA, Iparraguirre-López H, Gamboa-Cárdenas RV, Reátegui-Sokolova C, Zevallos-Miranda F, Medina-Chinchon M, Pimentel-Quiroz VR, Elera-Fitzcarrald C, Sarmiento-Velasquez O, Cucho-Venegas JM, Alfaro-Lozano JL, Rodríguez-Bellido ZJ, Pastor-Asurza CA, Perich-Campos RA, Alarcón GS, Ugarte-Gil MF.
    Clin Rheumatol; 2019 Apr; 38(4):1139-1146. PubMed ID: 30539353
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Damage accumulation in systemic lupus erythematosus and its relation to disease activity and mortality.
    Becker-Merok A, Nossent HC.
    J Rheumatol; 2006 Aug; 33(8):1570-7. PubMed ID: 16845708
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Disease evolution in late-onset and early-onset systemic lupus erythematosus.
    Aljohani R, Gladman DD, Su J, Urowitz MB.
    Lupus; 2017 Oct; 26(11):1190-1196. PubMed ID: 28420066
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The early protective effect of hydroxychloroquine on the risk of cumulative damage in patients with systemic lupus erythematosus.
    Akhavan PS, Su J, Lou W, Gladman DD, Urowitz MB, Fortin PR.
    J Rheumatol; 2013 Jun; 40(6):831-41. PubMed ID: 23588942
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The majority of Swedish systemic lupus erythematosus patients are still affected by irreversible organ impairment: factors related to damage accrual in two regional cohorts.
    Frodlund M, Reid S, Wetterö J, Dahlström Ö, Sjöwall C, Leonard D.
    Lupus; 2019 Sep; 28(10):1261-1272. PubMed ID: 31296137
    [Abstract] [Full Text] [Related]

  • 31. Predictors of low disease activity and clinical remission following belimumab treatment in systemic lupus erythematosus.
    Parodis I, Johansson P, Gomez A, Soukka S, Emamikia S, Chatzidionysiou K.
    Rheumatology (Oxford); 2019 Dec 01; 58(12):2170-2176. PubMed ID: 31157891
    [Abstract] [Full Text] [Related]

  • 32. Predictors of organ damage in systemic lupus erythematosus: the Hopkins Lupus Cohort.
    Petri M, Purvey S, Fang H, Magder LS.
    Arthritis Rheum; 2012 Dec 01; 64(12):4021-8. PubMed ID: 22932985
    [Abstract] [Full Text] [Related]

  • 33. Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus.
    Enocsson H, Wirestam L, Dahle C, Padyukov L, Jönsen A, Urowitz MB, Gladman DD, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Ginzler E, Alarcón GS, Chatham WW, Petri M, Khamashta M, Aranow C, Mackay M, Dooley MA, Manzi S, Ramsey-Goldman R, Nived O, Steinsson K, Zoma AA, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, van Vollenhoven RF, Ramos-Casals M, Kamen DL, Jacobsen S, Peschken CA, Askanase A, Stoll T, Bruce IN, Wetterö J, Sjöwall C.
    J Autoimmun; 2020 Jan 01; 106():102340. PubMed ID: 31629628
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Risk Factors for Chronic Damage Accumulation Across Different Onset Eras in Systemic Lupus Erythematosus: A Cross-sectional Analysis of a Lupus Registry of Nationwide Institutions (LUNA).
    Ohashi K, Sada KE, Asano Y, Hayashi K, Yamamura Y, Asano SH, Miyawaki Y, Morishita M, Katsuyama E, Watanabe H, Tatebe N, Narazaki M, Matsumoto Y, Sunahori-Watanabe K, Kawabata T, Yajima N, Wada J.
    Acta Med Okayama; 2020 Jun 01; 74(3):191-198. PubMed ID: 32577016
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Evaluating the Properties of a Frailty Index and Its Association With Mortality Risk Among Patients With Systemic Lupus Erythematosus.
    Legge A, Kirkland S, Rockwood K, Andreou P, Bae SC, Gordon C, Romero-Diaz J, Sanchez-Guerrero J, Wallace DJ, Bernatsky S, Clarke AE, Merrill JT, Ginzler EM, Fortin P, Gladman DD, Urowitz MB, Bruce IN, Isenberg DA, Rahman A, Alarcón GS, Petri M, Khamashta MA, Dooley MA, Ramsey-Goldman R, Manzi S, Steinsson K, Zoma AA, Aranow C, Mackay M, Ruiz-Irastorza G, Lim SS, Inanc M, van Vollenhoven RF, Jonsen A, Nived O, Ramos-Casals M, Kamen DL, Kalunian KC, Jacobsen S, Peschken CA, Askanase A, Hanly JG.
    Arthritis Rheumatol; 2019 Aug 01; 71(8):1297-1307. PubMed ID: 30771242
    [Abstract] [Full Text] [Related]

  • 39. Toward electronic health recording: evaluation of electronic patient reported outcome measures (e-PROMs) system for remote monitoring of early systemic lupus patients.
    El Miedany Y, El Gaafary M, El Aroussy N, Bahlas S, Hegazi M, Palmer D, Youssef S.
    Clin Rheumatol; 2017 Nov 01; 36(11):2461-2469. PubMed ID: 28567555
    [Abstract] [Full Text] [Related]

  • 40. Disease duration, hypertension and medication requirements are associated with organ damage in childhood-onset systemic lupus erythematosus.
    Lilleby V, Flatø B, Førre O.
    Clin Exp Rheumatol; 2005 Nov 01; 23(2):261-9. PubMed ID: 15895902
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.